Who owns Eledon Pharmaceuticals, Inc.?
Institutional ownership of ELDN from SEC Form 13F filings across 116 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
116
13F holders
$105.2M
value, 2026 filers
34.9%
of shares outstanding (27.0M sh)
38
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of ELDN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 5.1M | $20.2M | 0.0% | 6.6% | +16.9% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 3.4M | $13.5M | 0.0% | 4.4% | -48.1% |
| 3 | GOLDMAN SACHS GROUP INC | 2.5M | $9.9M | 0.0% | 3.3% | +578.3% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 2.0M | $7.7M | 0.0% | 2.5% | +9.2% |
| 5 | Catalio Capital Management, LP | 1.7M | $6.7M | 1.3% | 2.2% | +3.4% |
| 6 | Zimmer Partners, LP | 1.6M | $6.3M | 0.1% | 2.1% | -14.8% |
| 7 | UBS Group AG | 1.0M | $4.1M | 0.0% | 1.4% | +91.5% |
| 8 | KINGDON CAPITAL MANAGEMENT, L.L.C. | 1.0M | $4.1M | 0.4% | 1.3% | 0.0% |
| 9 | MILLENNIUM MANAGEMENT LLCNEW | 979,712 | $3.9M | 0.0% | 1.3% | new |
| 10 | BANK OF AMERICA CORP /DE/ | 883,097 | $3.5M | 0.0% | 1.1% | +1.6% |
| 11 | NORTHERN TRUST CORP | 616,399 | $2.4M | 0.0% | 0.8% | +13.3% |
| 12 | Blue Owl Capital Holdings LP | 566,509 | $2.2M | 0.3% | 0.7% | -60.1% |
| 13 | VANGUARD PORTFOLIO MANAGEMENT LLC | 533,365 | $2.1M | 0.0% | 0.7% | +24.1% |
| 14 | VANGUARD FIDUCIARY TRUST CO | 528,963 | $2.1M | 0.0% | 0.7% | +5.0% |
| 15 | MORGAN STANLEY | 485,092 | $1.9M | 0.0% | 0.6% | +234.2% |
| 16 | Brevan Howard Capital Management LP | 304,707 | $1.2M | 0.0% | 0.4% | +33.3% |
| 17 | Triumph Capital ManagementNEW | 303,443 | $1.2M | 0.2% | 0.4% | new |
| 18 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 252,232 | $993,794 | 0.0% | 0.3% | +129.4% |
| 19 | Sixth Street Partners Management Company, L.P.NEW | 247,404 | $974,772 | 0.2% | 0.3% | new |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 247,404 | $974,772 | 0.0% | 0.3% | +27.5% |
| 21 | CITADEL ADVISORS LLCNEW | 215,973 | $850,934 | 0.0% | 0.3% | new |
| 22 | Nuveen, LLC | 209,097 | $823,842 | 0.0% | 0.3% | +174.1% |
| 23 | Bank of New York Mellon Corp | 166,927 | $657,690 | 0.0% | 0.2% | +15.8% |
| 24 | Cambridge Investment Research Advisors, Inc. | 119,890 | $472 | 0.0% | 0.2% | +148.7% |
| 25 | LPL Financial LLC | 111,695 | $440,078 | 0.0% | 0.1% | +49.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.